US firm Albany Molecular Research (AMRI) has opened a new multimillion dollar research and development facility in Hyderabad, India, confirming its commitment to the region.
It is the third big investment the firm is making in India in less than three months.
The new $8m (€5.8m) R&D centre, located near AMRI's existing chemistry plants, will provide additional space for the company's laboratory-scale Indian operations.
|
|
Post a Comment